Ideaya Biosciences Inc

NASDAQ:IDYA   3:59:55 PM EDT
10.53
+0.16 (+1.54%)
Earnings Announcements

Ideaya Biosciences, Inc. Reports First Quarter 2022 Financial Results And Provides Business Update

Published: 05/10/2022 10:15 GMT
Ideaya Biosciences Inc (IDYA) - Ideaya Biosciences, Inc. Reports First Quarter 2022 Financial Results and Provides Business Update.
Ideaya Biosciences - About $346 Million Cash, Cash Equivalents & Marketable Securities As of March 31, 2022, Expected to Fund Planned Operations Into 2025.
Ideaya Biosciences - On-track to Submit Ind in Q4 2022 for Ide161, a Parg Development Candidate, & Nominate Pol Theta Development Candidate in Q2 2022.
Qtrly Net Loss per Share Attributable to Common Stockholders, Basic and Diluted $0.36.
Q1 Earnings per Share View $-0.41 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $5.39 Million
Adjusted EPS is expected to be -$0.52

Next Quarter Revenue Guidance is expected to be $12.57 Million
Next Quarter EPS Guidance is expected to be -$0.39

More details on our Analysts Page.